Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules

In tick-borne encephalitis (TBE)-endemic regions, long-term vaccination programs are efficient in preventing the disease. A booster dose of a polygeline-free inactivated TBE vaccine (Encepur Adults, GSK), administered approximately 3 years post-primary vaccination according to 1 of 3 licensed vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantini, Marco, Callegaro, Andrea, Beran, Jiří, Berlaimont, Valérie, Galgani, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553683/
https://www.ncbi.nlm.nih.gov/pubmed/31951780
http://dx.doi.org/10.1080/21645515.2019.1700712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553683/
https://www.ncbi.nlm.nih.gov/pubmed/31951780
http://dx.doi.org/10.1080/21645515.2019.1700712

Ejemplares similares